Glioblastoma Clinical Trials in Miami, FL

View the best 10 glioblastoma medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Glioblastoma clinical trial.

Trials in Miami, Florida

Here are the top 9 medical studies for glioblastoma in Miami, Florida

DB107-RRV +1 More

Virus Therapy

Recruiting1 awardPhase 2

This trial aims to see if a new combination treatment can reduce the size of a type of brain cancer called high-grade glioma in patients with recurrent or progressive disease, whether the tumor can be surgically

Temozolomide +1 More

Chemotherapy

Recruiting1 awardPhase 3

This trial is testing a treatment for newly diagnosed brain cancer patients. They are comparing the effectiveness of a new treatment called Optune with chemotherapy and immunotherapy to a combination of Optune with chemotherapy alone.

Bevacizumab +1 More

Angiogenesis Inhibitor

Recruiting1 awardPhase 2

This trial is testing if adding nivolumab to radiation therapy and bevacizumab improves treatment for recurrent glioblastoma.

Girentuximab

Recruiting1 awardPhase 2

This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.

Azeliragon

Chemotherapy

Recruiting1 awardPhase 2

This trial is testing a pill called azeliragon along with radiation therapy for a fast-growing brain cancer called 'unmethylated' glioblastoma. This type of cancer doesn't respond well to standard chemotherapy. The pill might help radiation work better and slow down the cancer's growth.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award

This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.

Optune®

Device

Recruiting1 award12 criteria

This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2

This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3

This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.

Popular Filters

Trials With No Placebo

Radiosensitizer

Ropidoxuridine for Glioblastoma

Recruiting1 awardPhase 2

Miami, Florida

"This trial is testing a drug called ropidoxuridine to see if it can make radiation therapy more effective in patients with a specific type of brain cancer. The study will look at how safe and

Virus Therapy

DB107-RRV + DB107-FC for Brain Tumors

Recruiting1 awardPhase 2

Miami, Florida

This trial aims to see if a new combination treatment can reduce the size of a type of brain cancer called high-grade glioma in patients with recurrent or progressive disease, whether the tumor can be surgically

Chemotherapy

Azeliragon for Glioblastoma

Recruiting1 awardPhase 2

Miami, Florida

This trial is testing a pill called azeliragon along with radiation therapy for a fast-growing brain cancer called 'unmethylated' glioblastoma. This type of cancer doesn't respond well to standard chemotherapy. The pill might help radiation work better and slow down the cancer's growth.

Monoclonal Antibodies

Cetuximab + Bevacizumab for Brain Tumor

Recruiting1 awardPhase 1 & 2

Miami, Florida

This trial tests if monthly infusions of cetuximab and bevacizumab can safely and effectively treat young people with brain tumors.

Chemotherapy

Ultrasound-Assisted Chemotherapy for Glioblastoma

Recruiting2 awardsPhase 3

Miami, Florida

This trial tests a new method to treat recurrent brain cancer using an ultrasound device called SonoCloud-9. The device helps open the brain's protective barrier so that more of the chemotherapy drug carboplatin can reach the tumor. The goal is to see if this combination makes the treatment more effective. Carboplatin has been used in various studies for treating high-grade gliomas and glioblastomas, often showing modest efficacy due to low tissue concentration when delivered intravenously.

89Zr-girentuximab PET Imaging for Cancer

Recruiting1 awardPhase 2

Miami, Florida

This trial will look at how well an imaging scan can detect and track cancer activity in people with solid tumors.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.